AETHLON MEDICAL INC
For the period ended Mar 31, 2024. Filed Jun 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jun 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints James B. Frakes his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ JAMES B. FRAKES | Interim Chief Executive Officer and Chief Financial Officer, Principal Executive Officer, Principal Financial and Accounting Officer and Director | June 27, 2024 |
| James B. Frakes | ||
| /s/ EDWARD G. BROENNIMAN | Chairman and Director | June 27, 2024 |
| Edward G. Broenniman | ||
| /s/ CHETAN S. SHAH | Director | June 27, 2024 |
| Chetan S. Shah, M.D. | ||
| /s/ ANGELA ROSSETTI | Director | June 27, 2024 |
| Angela Rossetti | ||
| /s/ NICOLAS GIKAKIS | Director | June 27, 2024 |
| Nicolas Gikakis | ||
| Page | |
| Consolidated Financial Statements | |
|---|---|
| Report of Independent Registered Public Accounting Firm (Baker Tilly US, LLP, San Diego, CA PCAOB ID No. 23) | F-2 |
| Consolidated Balance Sheets as of March 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years Ended March 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Equity for the Years Ended March 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Cash Flows for the Years Ended March 31, 2024 and 2023 | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.